Journal Articles Conference Presentations Book Chapters Public Presentations

Biomarkers for cystic fibrosis: are we progressing?

Alton EW, Davies JC, Geddes DM

American Journal Of Respiratory And Critical Care Medicine

Am J Respir Crit Care Med. 2007 Apr 15;175(8):750-1.

Print this page

Go Back to Publications     View on Pubmed (17405939)    View on Google Scholar


 

Other Publications by these authors
Lung clearance index in primary ciliary dyskinesia and bronchiectasis.
Irving SJ et al. American Journal Of Respiratory And Critical Care Medicine (2014) Gene therapy in cystic fibrosis.
Armstrong DK et al. Archives Of Disease In Childhood (2014) Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Alton EW et al. Gene Therapy (2013) The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
Alton EW et al. Biomaterials (2013) A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
Alton EW et al. Thorax (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
Horsley AR et al. Thorax (2013)